IT'S OFFICIAL. THIS IS THE WORST COMPANY EVER!

Discussion in 'MannKind' started by anonymous, Apr 7, 2018 at 2:15 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Company stock devalued again by Costanza! Costanza brings in Slick Pat and Nassi the Natzi who ruin the culture in record breaking time! Bonus changed to insure no one gets paid! Moral at all time low! No trust! No respect! No resources! No CDES! No raises! No sales! The laughing stock of the industry! Worst company ever!
     
    Steve Berger likes this.

  2. anonymous

    anonymous Guest

    You mean you don’t like the “but wait there’s more” like:
    Counting scripts at 1/4 or 1/3 or 1/2 a script instead of a full script. Imagine selling any product in the history of pharma and they say we will pay you 1/3 for 5mg a 1/2 for 10mg and full script for 20mg.
    If you don’t like it leave. Other than that get some lube and enjoy the ride. Because you’re about to get screwed.
     
    Steve Berger likes this.
  3. anonymous

    anonymous Guest

    The most F Up company ever. It gets intolerable by the day. Put us out of our misery. Sell us, trade us, fire us. Stop screwing us.
     
    Steve Berger likes this.
  4. anonymous

    anonymous Guest

    But wait there’s more.
    More Dilution to pay for high salaries of friends of friends of friends of Executive leadership
    More Debt
    More manage care coverage... nope never going to happen..
     
    Steve Berger likes this.
  5. anonymous

    anonymous Guest

    But wait, there’s more
    Instead of $60-$100,000 in bonus you can now make $8,000 guaranteed at goal. Fun.
     
    Steve Berger likes this.
  6. anonymous

    anonymous Guest

    But wait there is more, there were 519 RXs last week! Natzi and Astelles are heroes! But wait there is more, RXs plummeted this week and are again below 500! It's the fault of the sales force. Quick Natzi, fire someone!
     
    Steve Berger likes this.
  7. anonymous

    anonymous Guest

    But wait, there's more: Mannkind stock is down to $1.69. Lookout someone is hoping for an acquisition!
     
    Steve Berger likes this.